GISYX
Price
$19.88
Change
-$0.14 (-0.70%)
Updated
Sep 2 closing price
Net Assets
1.17B
OSMCX
Price
$31.42
Change
+$0.01 (+0.03%)
Updated
Sep 2 closing price
Net Assets
2.38B
Interact to see
Advertisement

GISYX vs OSMCX

GISYX vs OSMCX Comparison Chart in %
View a ticker or compare two or three
VS
GISYX vs. OSMCX commentary
Sep 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GISYX is a Hold and OSMCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
OSMCX has more cash in the bank: 2.38B vs. GISYX (1.17B). OSMCX pays higher dividends than GISYX: OSMCX (0.79) vs GISYX (0.68). GISYX was incepted earlier than OSMCX: GISYX (11 years) vs OSMCX (29 years). OSMCX (2.18) is less costly to investors than GISYX (0.90). GISYX is a more actively managed with annual turnover of: 71.00 vs. OSMCX (52.00). GISYX (1000) and OSMCX (1000) have matching initial minimum investment requirements. GISYX annual gain was more profitable for investors over the last year : 13.51 vs. OSMCX (-10.39). GISYX return over 5 years is better than : -26.94 vs. OSMCX (-44.83).
GISYXOSMCXGISYX / OSMCX
Total Expense Ratio0.902.1841%
Annual Report Gross Expense Ratio0.902.1841%
Fund Existence11 years29 years-
Gain YTD12.9808.610151%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.17B2.38B49%
Annual Yield % from dividends0.680.7987%
Returns for 1 year13.51-10.39-130%
Returns for 3 years25.88-9.24-280%
Returns for 5 years-26.94-44.8360%
Returns for 10 years74.69-10.78-693%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHPIX46.61N/A
N/A
ProFunds Pharmaceuticals UltraSector Inv
PMBMX37.19N/A
N/A
Principal MidCap R3
GDSTX32.86N/A
N/A
Goldman Sachs Small Cap Eq Insghts Inv
PGOAX23.35N/A
N/A
PGIM Jennison Small Company A
HLMVX33.80N/A
N/A
Harding Loevner Global Equity Inst